INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

In patients with type 2 diabetes, daily resveratrol increased skeletal muscle SIRT1 expression and resting metabolic rate but reduced daily physical activity.

Ten subjects with type 2 diabetes mellitus were randomized to receive 3 g resveratrol or placebo daily for 12 weeks. Compared with placebo, resveratrol significantly increased skeletal muscle SIRT1 expression (2.01 vs. 0.86 AU, p = .016) and the p-AMPK to AMPK ratio (2.04 vs. 0.79 AU, p = .032). Resveratrol also increased the percentage absolute change in resting metabolic rate (8.6 vs. -13.9%, p = .033) and percentage of predicted resting metabolic rate (7.8 vs. -13.9%, p = .013), but caused significant reductions in average daily activity (-38 vs. 43.2%, p = .028) and step counts (-39.5 vs. 11.8%, p = .047).

Study type
Double-blind randomized controlled trial
Who was studied
10 subjects with type 2 diabetes mellitus
What was measured
Skeletal muscle SIRT1 expression and energy expenditure

THE PAPER

Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.

Goh KP, Lee HY, Lau DP, Supaat W, Chan YH, Koh AF. Int J Sport Nutr Exerc Metab, 2014.

PubMed 23918588 ↗DOI 10.1123/ijsnem.2013-0045 ↗

Diabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.